548 related articles for article (PubMed ID: 23192075)
1. Safety and efficacy of oral transmucosal fentanyl citrate for prehospital pain control on the battlefield.
Wedmore IS; Kotwal RS; McManus JG; Pennardt A; Talbot TS; Fowler M; McGhee L
J Trauma Acute Care Surg; 2012 Dec; 73(6 Suppl 5):S490-5. PubMed ID: 23192075
[TBL] [Abstract][Full Text] [Related]
2. A randomized clinical trial of oral transmucosal fentanyl citrate versus intravenous morphine sulfate for initial control of pain in children with extremity injuries.
Mahar PJ; Rana JA; Kennedy CS; Christopher NC
Pediatr Emerg Care; 2007 Aug; 23(8):544-8. PubMed ID: 17726413
[TBL] [Abstract][Full Text] [Related]
3. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial.
Mercadante S; Radbruch L; Davies A; Poulain P; Sitte T; Perkins P; Colberg T; Camba MA
Curr Med Res Opin; 2009 Nov; 25(11):2805-15. PubMed ID: 19792837
[TBL] [Abstract][Full Text] [Related]
4. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.
Portenoy RK; Payne R; Coluzzi P; Raschko JW; Lyss A; Busch MA; Frigerio V; Ingham J; Loseth DB; Nordbrock E; Rhiner M
Pain; 1999 Feb; 79(2-3):303-12. PubMed ID: 10068176
[TBL] [Abstract][Full Text] [Related]
5. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
Landy SH
Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
[TBL] [Abstract][Full Text] [Related]
6. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
7. The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain.
Lichtor JL; Sevarino FB; Joshi GP; Busch MA; Nordbrock E; Ginsberg B
Anesth Analg; 1999 Sep; 89(3):732-8. PubMed ID: 10475315
[TBL] [Abstract][Full Text] [Related]
8. Trends in Prehospital Analgesia Administration by US Forces From 2007 Through 2016.
Schauer SG; Naylor JF; Maddry JK; Hinojosa-Laborde C; April MD
Prehosp Emerg Care; 2019; 23(2):271-276. PubMed ID: 30118637
[TBL] [Abstract][Full Text] [Related]
9. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.
Parikh N; Goskonda V; Chavan A; Dillaha L
Clin Ther; 2013 Mar; 35(3):236-43. PubMed ID: 23497761
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the paramedic administration of fentanyl.
Garrick JF; Kidane S; Pointer JE; Sugiyama W; Van Luen C; Clark R
J Opioid Manag; 2011; 7(3):229-34. PubMed ID: 21823553
[TBL] [Abstract][Full Text] [Related]
11. A novel pain management strategy for combat casualty care.
Kotwal RS; O'Connor KC; Johnson TR; Mosely DS; Meyer DE; Holcomb JB
Ann Emerg Med; 2004 Aug; 44(2):121-7. PubMed ID: 15278083
[TBL] [Abstract][Full Text] [Related]
12. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients.
Farrar JT; Cleary J; Rauck R; Busch M; Nordbrock E
J Natl Cancer Inst; 1998 Apr; 90(8):611-6. PubMed ID: 9554444
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of patient-controlled analgesia for patients with acute abdominal pain in the emergency department: a randomized trial.
Birnbaum A; Schechter C; Tufaro V; Touger R; Gallagher EJ; Bijur P
Acad Emerg Med; 2012 Apr; 19(4):370-7. PubMed ID: 22506940
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of fentanyl administration for prehospital pain management.
Kanowitz A; Dunn TM; Kanowitz EM; Dunn WW; Vanbuskirk K
Prehosp Emerg Care; 2006; 10(1):1-7. PubMed ID: 16418084
[TBL] [Abstract][Full Text] [Related]
15. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).
Coluzzi PH; Schwartzberg L; Conroy JD; Charapata S; Gay M; Busch MA; Chavez J; Ashley J; Lebo D; McCracken M; Portenoy RK
Pain; 2001 Mar; 91(1-2):123-30. PubMed ID: 11240084
[TBL] [Abstract][Full Text] [Related]
16. Danish pain specialists' rationales behind the choice of fentanyl transdermal patches and oral transmucosal systems--a delphi study.
Jacobsen R; Møldrup C; Christrup L
Pain Med; 2009 Nov; 10(8):1442-51. PubMed ID: 19793344
[TBL] [Abstract][Full Text] [Related]
17. Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain.
Mercadante S; Villari P; Ferrera P; Casuccio A; Mangione S; Intravaia G
Br J Cancer; 2007 Jun; 96(12):1828-33. PubMed ID: 17519902
[TBL] [Abstract][Full Text] [Related]
18. Oral transmucosal fentanyl citrate analgesia in prehospital trauma care: an observational cohort study.
Pietsch U; Fischer H; Rüst CA; Hossfeld B; Grünenfelder A; Wenzel V; Albrecht R
Scand J Trauma Resusc Emerg Med; 2023 Jan; 31(1):2. PubMed ID: 36609399
[TBL] [Abstract][Full Text] [Related]
19. Opioid analgesia on the battlefield: a retrospective review of data from Operation HERRICK.
Lewis P; Wright C; Hooper C
J R Army Med Corps; 2018 Sep; 164(5):328-331. PubMed ID: 29626143
[TBL] [Abstract][Full Text] [Related]
20. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.
Christie JM; Simmonds M; Patt R; Coluzzi P; Busch MA; Nordbrock E; Portenoy RK
J Clin Oncol; 1998 Oct; 16(10):3238-45. PubMed ID: 9779697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
